Warning letter

United Metabolic Research Center: warning letter of Mar 24, 2000

FDA warning letter UCM068273 · Atlanta District Office

Key facts

Reference number UCM068273
Company United Metabolic Research Center
Subject Betadrene-SR/Lacks Approved New Drug Application
Issue date Mar 24, 2000
Posted date Mar 24, 2000
Issuing office Atlanta District Office
Product type Drugs
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters